Bio-Rad(BIO) - 2025 Q4 - Annual Results

Exhibit 99.1 Press Release Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results HERCULES, Calif.—February 12, 2026 -- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the fourth quarter and full-year ended December 31, 2025. Norman Schwartz, Bio-Rad's Chief Executive Officer, stated: "2025 was a challenging year with geopolitical uncertainty and continued pressure on academic res ...